chr22:22113946:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr22:22,113,946-22,221,970 |
hg38 | chr22:21,759,657-21,867,680 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.137 | squamous cell carcinoma | Licochalcone-A induces intrinsic and extrinsic apoptosis via ERK1/2 and p38 phos... | BeFree,CTD_human,LHGDN | 25572524 | Detail |
0.137 | squamous cell carcinoma | Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p3... | BeFree,CTD_human,LHGDN | 25721086 | Detail |
<0.001 | Cardiomyopathy, Dilated | NA | BeFree | Detail | |
0.120 | brain ischemia | NA | CTD_human | Detail | |
<0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
<0.001 | Developmental Disabilities | NA | BeFree | Detail | |
0.003 | cholesteatoma | NA | BeFree,LHGDN | Detail | |
0.001 | chondrosarcoma | NA | BeFree | Detail | |
<0.001 | chordoma | NA | BeFree | Detail | |
<0.001 | choriocarcinoma | CXCL12-CXCR7 signaling activates ERK and Akt pathways in human choriocarcinoma c... | BeFree | 24450273 | Detail |
0.001 | colitis | In TNBS-induced mouse colitis models, we observed the up-regulation of VPS4B was... | BeFree | 25533544 | Detail |
0.001 | ulcerative colitis | NA | BeFree | Detail | |
0.014 | Colonic Neoplasms | Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived x... | BeFree,LHGDN | 25890501 | Detail |
0.008 | colorectal carcinoma | Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in c... | BeFree | 25051350 | Detail |
0.008 | colorectal carcinoma | Taken together, the present study demonstrated that BK increases IL-6 production... | BeFree | 25109623 | Detail |
0.008 | colorectal carcinoma | In conclusion, PXN promotes Bcl-2 phosphorylation at Serine 87 via PXN-mediated ... | BeFree | 25826088 | Detail |
0.008 | colorectal carcinoma | Taken together, our study's findings indicate that the deregulation of β-catenin... | BeFree | 26267535 | Detail |
0.006 | Colorectal Neoplasms | TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphory... | BeFree,LHGDN | 25239454 | Detail |
0.006 | Colorectal Neoplasms | Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-me... | BeFree,LHGDN | 25826088 | Detail |
0.002 | Crohn Disease | Vacuolar protein sorting 4B regulates apoptosis of intestinal epithelial cells v... | BeFree | 25533544 | Detail |
0.003 | adenoid cystic carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | cystic fibrosis | NA | BeFree | Detail | |
<0.001 | Cytomegalovirus Infections | NA | BeFree | Detail | |
0.003 | Cessation of life | NA | LHGDN | Detail | |
<0.001 | depressive disorder | NA | BeFree | Detail | |
<0.001 | Dermatitis, Atopic | NA | BeFree | Detail | |
<0.001 | scleroderma | NA | BeFree | Detail | |
0.001 | diabetes mellitus | NA | BeFree | Detail | |
0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
<0.001 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree | Detail | |
<0.001 | Diabetes Mellitus, Non-Insulin-Dependent | Our results indicated the considerably aberrant MAPK signaling in both insulin-s... | BeFree | 25758573 | Detail |
<0.001 | Diabetic Angiopathies | Our results indicate that an MKP-3 pathway might regulate ERK dephosphorylation ... | BeFree | 25014566 | Detail |
<0.001 | Diabetic Nephropathy | NA | BeFree | Detail | |
<0.001 | DiGeorge syndrome | NA | BeFree | Detail | |
<0.001 | Dwarfism | NA | BeFree | Detail | |
<0.001 | echinococcosis | NA | BeFree | Detail | |
<0.001 | Eczema | NA | BeFree | Detail | |
0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
0.004 | endometriosis | Lipoxin A4 suppresses the development of endometriosis in an ALX receptor-depend... | BeFree,LHGDN | 24923883 | Detail |
0.004 | endometriosis | Up-regulation of Bcl-2 by CD147 Through ERK Activation Results in Abnormal Cell ... | BeFree,LHGDN | 25996258 | Detail |
<0.001 | Enteritis | NA | BeFree | Detail | |
<0.001 | epidermodysplasia verruciformis | NA | BeFree | Detail | |
<0.001 | epilepsy | NA | BeFree | Detail | |
0.004 | Esophageal Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | Fanconi anemia | NA | BeFree | Detail | |
<0.001 | fibrodysplasia ossificans progressiva | NA | BeFree | Detail | |
0.003 | Fibrosis | NA | LHGDN | Detail | |
0.007 | glioblastoma | Taken together, p38 MAPK-MK2-HuR signalling may enhance the potential of intrins... | BeFree,LHGDN | 25088200 | Detail |
0.007 | glioblastoma | Application of a specific extracellular-related kinase 1/2 (ERK1/2) inhibitor, b... | BeFree,LHGDN | 25213694 | Detail |
0.009 | Glioma | Here we propose that the blinding of cell-cell contact sensing in gliomas is cau... | BeFree,LHGDN | 24858041 | Detail |
0.009 | Glioma | Furthermore, AND did not induce apoptosis or activate ERK and p53 in primary cul... | BeFree,LHGDN | 25162007 | Detail |
0.009 | Glioma | Taken together, our findings showed that HDAC3 contributed to VM in gliomas, pos... | BeFree,LHGDN | 25940092 | Detail |
0.120 | Gliosis | NA | CTD_human | Detail | |
<0.001 | glomerulonephritis | NA | BeFree | Detail | |
0.120 | IgA glomerulonephritis | NA | CTD_human | Detail | |
0.120 | Head and Neck Neoplasms | NA | CTD_human | Detail | |
0.083 | Cardiomegaly | NA | LHGDN,RGD | Detail | |
0.002 | Heart failure | NA | BeFree | Detail | |
0.002 | congestive heart failure | NA | BeFree | Detail | |
<0.001 | Severe Dengue | Syk and ERK may serve as new therapeutic targets for interfering with ADE-induce... | BeFree | 26032420 | Detail |
<0.001 | hepatitis B | NA | BeFree | Detail | |
0.003 | hepatitis C | NA | BeFree,LHGDN | Detail | |
0.008 | HIV Infections | The results of BNDF research show that neurotrophins regulate miRNAs in at least... | BeFree,GAD | 25544363 | Detail |
0.120 | Hyperalgesia | NA | CTD_human | Detail | |
0.005 | hyperglycemia | The sEng, sFlt-1, and interleukin-6 were up-regulated, whereas the VEGF and PlGF... | BeFree,LHGDN | 24793974 | Detail |
0.005 | hyperglycemia | These results indicate that high AR expression in the context of hyperglycemia a... | BeFree,LHGDN | 25541468 | Detail |
0.005 | hyperglycemia | Our results indicated the considerably aberrant MAPK signaling in both insulin-s... | BeFree,LHGDN | 25758573 | Detail |
<0.001 | hyperinsulinism | Irisin treatment significantly increased insulin-like growth factor 1 and decrea... | BeFree | 24614098 | Detail |
<0.001 | Hypertensive disease | NA | BeFree | Detail | |
<0.001 | Immune System Diseases | NA | BeFree | Detail | |
0.120 | Female infertility | NA | CTD_human | Detail | |
<0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
0.002 | influenza | Roles of p38 MAPK in the regulation of the inflammatory response to swine influe... | BeFree | 25518721 | Detail |
0.002 | ischemia | NA | BeFree | Detail | |
<0.001 | arthropathy | NA | BeFree | Detail | |
0.003 | actinic keratosis | NA | LHGDN | Detail | |
0.121 | Kidney Neoplasm | NA | BeFree,CTD_human | Detail | |
<0.001 | Fibroid Tumor | NA | BeFree | Detail | |
0.007 | leukemia | Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation o... | BeFree,LHGDN | 25955299 | Detail |
0.003 | chronic lymphocytic leukemia | We also found that blocking ET(A)R via BQ-123 interferes with ERK phosphorylatio... | BeFree | 24901342 | Detail |
0.003 | chronic lymphocytic leukemia | BRAF inhibitor-associated ERK activation drives development of chronic lymphocyt... | BeFree | 25329694 | Detail |
0.001 | hairy cell leukemia | NA | BeFree | Detail | |
<0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
0.002 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
0.002 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
<0.001 | Leukemia, Myelomonocytic, Chronic | NA | BeFree | Detail | |
<0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
0.002 | Liver neoplasms | NA | BeFree | Detail | |
0.127 | Lung Neoplasms | At the molecular level, reduced activation of ERK MAPK, but not Akt, was observe... | BeFree,CTD_human,LHGDN | 24727895 | Detail |
0.001 | Lupus Vulgaris | NA | BeFree | Detail | |
0.001 | Lupus Erythematosus, Discoid | NA | BeFree | Detail | |
0.003 | Lupus Erythematosus, Systemic | NA | BeFree | Detail | |
<0.001 | Lyme disease | NA | BeFree | Detail | |
0.005 | lymphoma | We discovered that YC-1 induces apoptosis and inhibits tumour growth of breast c... | BeFree,LHGDN | 24697523 | Detail |
0.005 | lymphoma | Mechanistically, SHP2/ERK inhibition impedes c-Myc transcriptional activity, whi... | BeFree,LHGDN | 25193962 | Detail |
<0.001 | Lymphoma, Follicular | NA | BeFree | Detail | |
<0.001 | Lymphoma, Non-Hodgkin | NA | BeFree | Detail | |
0.001 | malaria | NA | BeFree | Detail | |
0.009 | Malignant neoplasm of stomach | Resistin-induced stromal cell-derived factor-1 expression through Toll-like rece... | BeFree | 24929539 | Detail |
0.009 | Malignant neoplasm of stomach | Deactivation of phosphorylation of ERK protein is one of the mechanisms of soraf... | BeFree | 25136776 | Detail |
0.009 | Malignant neoplasm of stomach | These data suggest that heparanase facilitates invasion and migration of human g... | BeFree | 25337202 | Detail |
0.009 | Malignant neoplasm of stomach | Combined treatment with p38 activator partially blocked the antimetastatic effec... | BeFree | 25502212 | Detail |
0.009 | Malignant neoplasm of stomach | These results indicated that CARLo-5 might serve as a pro-oncogenic lncRNA that ... | BeFree | 25674211 | Detail |
0.009 | Malignant neoplasm of stomach | WISP-2 suppressed GC cell metastasis through reversing EMT and suppressing the e... | BeFree | 26291058 | Detail |
0.004 | medulloblastoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Mesothelioma | Mesothelioma tumors are locally invasive and our results clearly suggest that ac... | BeFree | 25557874 | Detail |
<0.001 | mitral valve stenosis | NA | BeFree | Detail | |
0.007 | multiple myeloma | In summary, our results suggest that quercetin suppresses the proliferation of M... | BeFree,LHGDN | 24397597 | Detail |
0.080 | Multiple Organ Failure | NA | RGD | Detail | |
0.123 | multiple sclerosis | NA | BeFree,GAD,GWASCAT | Detail | |
<0.001 | spinal muscular atrophy | NA | BeFree | Detail | |
<0.001 | myasthenia gravis | MAPK1 and RAF1 were responsible for most of this crosstalk (80%), likely reflect... | BeFree | 25705681 | Detail |
<0.001 | Mycobacterium Infections | NA | BeFree | Detail | |
0.080 | myocardial infarction | NA | RGD | Detail | |
0.080 | Myocardial Reperfusion Injury | NA | RGD | Detail | |
0.002 | narcolepsy | NA | GAD | Detail | |
0.120 | Neoplasm Invasiveness | NA | CTD_human | Detail | |
0.141 | Neoplasm Metastasis | Mechanistically, knockdown of FAP inactivated PTEN/PI3K/AKT and Ras-ERK and its ... | BeFree,CTD_human,LHGDN | 24722280 | Detail |
0.141 | Neoplasm Metastasis | Ubc13 was dispensable for transforming growth factor β (TGFβ)-induced SMAD activ... | BeFree,CTD_human,LHGDN | 25189770 | Detail |
0.141 | Neoplasm Metastasis | The oncogene ABL1 was a direct miR-3127-5p target, and miR-3127-5p regulated the... | BeFree,CTD_human,LHGDN | 25284075 | Detail |
0.141 | Neoplasm Metastasis | In conclusion, these findings demonstrate that EMT can be regulated by the CCL19... | BeFree,CTD_human,LHGDN | 25359618 | Detail |
0.141 | Neoplasm Metastasis | In conclusion, this study suggested that EMT process can be triggered by the BMP... | BeFree,CTD_human,LHGDN | 25448881 | Detail |
0.141 | Neoplasm Metastasis | Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by... | BeFree,CTD_human,LHGDN | 25828376 | Detail |
0.141 | Neoplasm Metastasis | We also show that mice that have tumors with intrinsically high levels of active... | BeFree,CTD_human,LHGDN | 25853295 | Detail |
0.141 | Neoplasm Metastasis | WISP-2 suppressed GC cell metastasis through reversing EMT and suppressing the e... | BeFree,CTD_human,LHGDN | 26291058 | Detail |
0.120 | Nerve Degeneration | NA | CTD_human | Detail | |
0.005 | neuroblastoma | CFM-4 and -5 induced apoptosis in NB cells in part by activating pro-apoptotic s... | BeFree | 25033461 | Detail |
0.005 | neuroblastoma | Moreover, the data show that inhibition of p38 MAPK signalling potentiates the a... | BeFree | 25086905 | Detail |
0.005 | neuroblastoma | A cell-based assay was developed using natively expressed ORL-1 receptors on mou... | BeFree | 25677767 | Detail |
0.005 | neuroblastoma | Mechanistically treatment of NBs with small molecule inhibitors of EGFR (erlotin... | BeFree | 25756510 | Detail |
0.005 | neuroblastoma | Furthermore, the amount of phosphorylation of the kinase ERK and neurite outgrow... | BeFree | 25921289 | Detail |
<0.001 | neurofibroma | NA | BeFree | Detail | |
<0.001 | neurofibromatosis 1 | Moving beyond BRAFV600 targeting, a number of other molecular subsets--such as m... | BeFree | 25993155 | Detail |
0.003 | Noonan syndrome | NA | BeFree | Detail | |
0.002 | obesity | Taking together, we demonstrate here for the first time that Arg-II causes eNOS-... | BeFree | 25034973 | Detail |
0.002 | obesity | Current data exclude a major function of these syntrophins in ABCA1 activity and... | BeFree | 25625330 | Detail |
<0.001 | Opioid withdrawal | Our data suggest that H2S prevents the development of opioid withdrawal-induced ... | BeFree | 24824948 | Detail |
0.002 | Degenerative polyarthritis | Our results showed that increased basal COL10A1 expression in OA hMSCs was signi... | BeFree | 25091567 | Detail |
0.003 | osteoporosis | NA | LHGDN | Detail | |
0.005 | osteosarcoma | Taken together, data show CTGF elevating MMPs expression and subsequently promot... | BeFree,LHGDN | 25003330 | Detail |
0.005 | osteosarcoma | Taken together, our data suggest that miR-143 inhibits EGFR signaling through it... | BeFree,LHGDN | 25227664 | Detail |
0.006 | ovarian carcinoma | These regulatory effects of EC on ovarian cancer cell proliferation, migration a... | BeFree | 24892518 | Detail |
0.006 | ovarian carcinoma | MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth fa... | BeFree | 25176450 | Detail |
0.006 | ovarian carcinoma | In conclusion, bortezomib may induce ERK phosphorylation to suppress cathepsin B... | BeFree | 25375375 | Detail |
0.006 | ovarian carcinoma | We conclude that the carboxy-terminal portion of the MUC16/CA125 protein is onco... | BeFree | 25965947 | Detail |
0.003 | Paget Disease Extramammary | NA | LHGDN | Detail | |
0.004 | Pancreatic Neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | Parkinson disease | ERK-mediated phosphorylation of TFAM downregulates mitochondrial transcription: ... | BeFree | 24768991 | Detail |
<0.001 | pemphigus vulgaris | NA | BeFree | Detail | |
<0.001 | periodontitis | NA | BeFree | Detail | |
<0.001 | Peripheral neuropathy | NA | BeFree | Detail | |
<0.001 | pheochromocytoma | NA | BeFree | Detail | |
<0.001 | pituitary adenoma | NA | BeFree | Detail | |
<0.001 | Pituitary Neoplasms | NA | BeFree | Detail | |
<0.001 | polycythemia vera | NA | BeFree | Detail | |
0.014 | Prostatic Neoplasms | NA | LHGDN | Detail | |
<0.001 | pseudomyxoma peritonei | We tested RDEA119, a specific MEK1/2 (MAPK extracellular signal-regulated kinase... | BeFree | 25890193 | Detail |
0.004 | psoriasis | NA | BeFree,LHGDN | Detail | |
<0.001 | Reoviridae Infections | NA | BeFree | Detail | |
<0.001 | Respiratory Syncytial Virus Infections | NA | BeFree | Detail | |
<0.001 | retinoblastoma | MEK/ERK inhibitors are also in clinical trials and the importance of pRB inactiv... | BeFree | 25070358 | Detail |
0.002 | rhabdomyosarcoma | NA | BeFree | Detail | |
<0.001 | Kaposi sarcoma | Taken together, our data suggest that miR99a inhibits MMP7 and MMP13 through PI3... | BeFree | 25234715 | Detail |
<0.001 | schizophrenia | NA | BeFree | Detail | |
0.004 | systemic scleroderma | NA | BeFree,LHGDN | Detail | |
<0.001 | scrub typhus | NA | BeFree | Detail | |
<0.001 | Seizures | NA | BeFree | Detail | |
0.120 | Sezary syndrome | NA | CTD_human | Detail | |
0.080 | Shock, Hemorrhagic | NA | RGD | Detail | |
<0.001 | Dermatologic disorders | NA | BeFree | Detail | |
0.128 | Stomach Neoplasms | NA | CTD_human,LHGDN | Detail | |
<0.001 | pheochromocytoma | When expressed in rat pheochromocytoma cell line cells, the R151C, R160W and D29... | BeFree | 19755124 | Detail |
<0.001 | substance dependence | NA | BeFree | Detail | |
0.120 | Substance Withdrawal Syndrome | NA | CTD_human | Detail | |
<0.001 | synovial sarcoma | NA | BeFree | Detail | |
<0.001 | thyroiditis | NA | BeFree | Detail | |
0.001 | tuberculosis | NA | BeFree | Detail | |
<0.001 | tuberous sclerosis | NA | BeFree | Detail | |
<0.001 | Unipolar Depression | Eighty percent of these genes were functionally associated with a key stress res... | BeFree | 25734512 | Detail |
0.080 | urethral obstruction | NA | RGD | Detail | |
0.080 | Urinary Incontinence | NA | RGD | Detail | |
<0.001 | Uterine Fibroids | NA | BeFree | Detail | |
0.003 | vaccinia | NA | LHGDN | Detail | |
<0.001 | varicocele | Subjects with varicocele demonstrated a significant negative correlation between... | BeFree | 26209830 | Detail |
0.002 | Virus Diseases | Increased activation of mitogen-activated protein kinase p38 and its substrate h... | BeFree | 25427614 | Detail |
<0.001 | Werner syndrome | NA | BeFree | Detail | |
<0.001 | Dental White Spot | NA | BeFree | Detail | |
<0.001 | yellow fever | MEK/ERK activation plays a decisive role in yellow fever virus replication: impl... | BeFree | 25241249 | Detail |
<0.001 | AIDS-Associated Nephropathy | NA | BeFree | Detail | |
0.002 | B-Cell Lymphomas | Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to sp... | BeFree | 24787013 | Detail |
0.002 | B-Cell Lymphomas | Lupalbigenin treatment significantly down-regulated survival proteins, including... | BeFree | 25964563 | Detail |
<0.001 | Lymphoma, Large-Cell, Follicular | NA | BeFree | Detail | |
<0.001 | Lymphoma, T-Cell, Cutaneous | NA | BeFree | Detail | |
<0.001 | Pleural Effusion, Malignant | NA | BeFree | Detail | |
<0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
<0.001 | Neurofibrillary degeneration (morphologic abnormality) | NA | BeFree | Detail | |
<0.001 | Polycystic Kidney, Autosomal Dominant | NA | BeFree | Detail | |
<0.001 | acute leukemia | NA | BeFree | Detail | |
<0.001 | Depressive Symptoms | NA | BeFree | Detail | |
<0.001 | Epstein-Barr Virus Infections | NA | BeFree | Detail | |
<0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | renal fibrosis | NA | BeFree | Detail | |
<0.001 | Cutaneous Melanoma | NA | BeFree | Detail | |
<0.001 | Dry skin | NA | BeFree | Detail | |
0.002 | Adenocarcinoma of lung (disorder) | LATS2 mRNA level was found to be a significant independent predictor for surviva... | BeFree | 24976335 | Detail |
0.002 | Adenocarcinoma of lung (disorder) | Genetic alterations affecting the MAPK/ERK pathway are common in lung adenocarci... | BeFree | 25351745 | Detail |
0.002 | Adenocarcinoma of lung (disorder) | To elucidate how EGFR signaling is linked to metabolic activity, we investigated... | BeFree | 26023239 | Detail |
<0.001 | esophageal carcinoma | NA | BeFree | Detail | |
<0.001 | Idiopathic pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of mouth | A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and... | BeFree | 25091805 | Detail |
<0.001 | Malignant neoplasm of gallbladder | ARB blocked A2-induced GBC cell growth and activated ERK. | BeFree | 25663464 | Detail |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of bone | NA | BeFree | Detail | |
0.120 | Streptococcal pneumonia | NA | CTD_human | Detail | |
<0.001 | allergic asthma | NA | BeFree | Detail | |
<0.001 | Intervertebral Disc Degeneration | NA | BeFree | Detail | |
<0.001 | Dermatitis, Allergic Contact | NA | BeFree | Detail | |
<0.001 | Sotos' syndrome | NA | BeFree | Detail | |
0.003 | Tumor Progression | Furthermore, while p53R2, a p53-inducible peptide involved in the synthesis of d... | BeFree | 25086499 | Detail |
0.003 | Tumor Progression | Given the multiple context-dependent roles for αvβ3 in angiogenesis and tumor pr... | BeFree | 25249331 | Detail |
<0.001 | Dysplastic Nevus | NA | BeFree | Detail | |
<0.001 | alveolar rhabdomyosarcoma | NA | BeFree | Detail | |
<0.001 | Rhabdomyosarcoma, Embryonal | Production of reactive oxygen species (ROS) and activation of p38 MAPK have a ce... | BeFree | 26153023 | Detail |
<0.001 | teratocarcinoma | NA | BeFree | Detail | |
<0.001 | adrenocortical carcinoma | NA | BeFree | Detail | |
0.003 | mucoepidermoid carcinoma | NA | BeFree,LHGDN | Detail | |
0.004 | cholangiocarcinoma | WWOX suppresses cell growth and induces cell apoptosis via inhibition of P38 nuc... | BeFree,LHGDN | 25502636 | Detail |
<0.001 | Cystadenocarcinoma, Serous | NA | BeFree | Detail | |
<0.001 | verrucous carcinoma | NA | BeFree | Detail | |
<0.001 | Nerve Sheath Tumors | NA | BeFree | Detail | |
<0.001 | Neuroendocrine Tumors | NA | BeFree | Detail | |
<0.001 | uveal melanoma | NA | BeFree | Detail | |
<0.001 | Lip and oral cavity carcinoma | A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and... | BeFree | 25091805 | Detail |
0.080 | Shprintzen syndrome | NA | BeFree,MGD | Detail | |
<0.001 | Intestinal carcinoma | Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large int... | BeFree | 25253956 | Detail |
<0.001 | Pulsus trigeminus | NA | BeFree | Detail | |
<0.001 | Memory impairment | NA | BeFree | Detail | |
<0.001 | Extrapyramidal sign | NA | BeFree | Detail | |
<0.001 | gallbladder carcinoma | ARB blocked A2-induced GBC cell growth and activated ERK. | BeFree | 25663464 | Detail |
0.007 | pancreatic carcinoma | Further analysis showed that Cyr61 seemed to activate phosphatidylinositol 3-kin... | BeFree | 25104090 | Detail |
0.007 | pancreatic carcinoma | ERK pathway knockdown suppressed pancreatic cancer cell proliferation, invasion,... | BeFree | 25646808 | Detail |
0.007 | pancreatic carcinoma | This fission is driven by Erk2-mediated phosphorylation of Drp1 on Serine 616, a... | BeFree | 25658205 | Detail |
0.007 | pancreatic carcinoma | We propose that dual PI3K/mTOR inhibitors suppress a novel negative feedback loo... | BeFree | 25673820 | Detail |
0.007 | pancreatic carcinoma | ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreat... | BeFree | 25753158 | Detail |
0.007 | pancreatic carcinoma | Selective inhibition of the p38 alternative activation pathway in infiltrating T... | BeFree | 26479921 | Detail |
0.120 | Cocaine-Related Disorders | NA | CTD_human | Detail | |
<0.001 | Gastrointestinal Stromal Tumors | Analysis of western blotting data showed that total protein isoforms of Raf, MEK... | BeFree | 24970355 | Detail |
<0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Medullary carcinoma of thyroid | Our investigation of the molecular mechanisms underlying these effects revealed ... | BeFree | 25435367 | Detail |
0.002 | Papillary thyroid carcinoma | Moreover, our results also showed that downregulation of NOB1 was able to signif... | BeFree | 25231838 | Detail |
0.002 | Papillary thyroid carcinoma | In addition, Ad/sh-NOB1 combined with DOX treatment significantly increased acti... | BeFree | 25592304 | Detail |
<0.001 | bone destruction | By using specific small hairpin RNAs for MAPK11, we demonstrated that p38β-media... | BeFree | 25066918 | Detail |
<0.001 | Fibrosis, Liver | NA | BeFree | Detail | |
<0.001 | Iron deficiency | NA | BeFree | Detail | |
0.007 | Malignant neoplasm of lung | The expression of tumour suppressor genes was reduced in tumours from current ve... | BeFree | 24727895 | Detail |
0.007 | Malignant neoplasm of lung | The results indicated that Sorcin may be used as a potential therapeutic target ... | BeFree | 25394367 | Detail |
0.007 | Malignant neoplasm of lung | Here, we reported that the AKT inhibitor perifosine and the MEK\ERK inhibitor ME... | BeFree | 25697899 | Detail |
<0.001 | Bare Lymphocyte Syndrome | NA | BeFree | Detail | |
<0.001 | Neoplasm, Residual | NA | BeFree | Detail | |
0.120 | Sepsis | NA | BeFree,CTD_human | Detail | |
<0.001 | Psoriasis vulgaris | NA | BeFree | Detail | |
<0.001 | Muckle-Wells syndrome | NA | BeFree | Detail | |
<0.001 | Isovaleryl-CoA dehydrogenase deficiency | Guanine nucleotide binding protein alpha13 (GNA13) and protein tyrosine phosphat... | BeFree | 25193986 | Detail |
<0.001 | Myelokathexis | NA | BeFree | Detail | |
<0.001 | Virchow's node (disorder) | Genome-wide analyses have identified four major signaling nodes that are most fr... | BeFree | 25070358 | Detail |
<0.001 | Disease due to Parvoviridae | NA | BeFree | Detail | |
<0.001 | Rhinovirus infection | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of colon stage IV | NA | BeFree | Detail | |
<0.001 | Carcinoma breast stage IV | NA | BeFree | Detail | |
<0.001 | Metastatic Renal Cell Cancer | C5aR is frequently expressed in metastatic renal cell carcinoma and plays a cruc... | BeFree | 25682807 | Detail |
0.001 | Metastatic melanoma | In this article, Paul B. Chapman, MD, Memorial Sloan Kettering Cancer Center, su... | BeFree | 24857055 | Detail |
0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells. | BeFree | 25747387 | Detail |
0.001 | Squamous cell carcinoma of esophagus | Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21... | BeFree | 25175641 | Detail |
0.001 | Squamous cell carcinoma of esophagus | Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pat... | BeFree | 25620088 | Detail |
<0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
<0.001 | cervical squamous cell carcinoma | The data indicate that CIN genomes harbor unfixed mutations in addition to human... | BeFree | 25738363 | Detail |
<0.001 | Solid tumour | In conclusion, bortezomib may induce ERK phosphorylation to suppress cathepsin B... | BeFree | 25375375 | Detail |
<0.001 | Oligodendroglioma, Childhood | Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediat... | BeFree | 25794445 | Detail |
0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
0.001 | cervix carcinoma | NA | BeFree | Detail | |
<0.001 | Hyperplastic Polyp | NA | BeFree | Detail | |
<0.001 | anaplastic astrocytoma | NA | BeFree | Detail | |
0.001 | pilocytic astrocytoma | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of colon | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of liver | Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells. | BeFree | 25747387 | Detail |
<0.001 | malignant mesothelioma | Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 ... | BeFree | 25557874 | Detail |
<0.001 | Malignant melanoma of choroid | NA | BeFree | Detail | |
0.006 | Malignant neoplasm of pancreas | ERK pathway knockdown suppressed pancreatic cancer cell proliferation, invasion,... | BeFree | 25646808 | Detail |
0.006 | Malignant neoplasm of pancreas | This fission is driven by Erk2-mediated phosphorylation of Drp1 on Serine 616, a... | BeFree | 25658205 | Detail |
0.006 | Malignant neoplasm of pancreas | We propose that dual PI3K/mTOR inhibitors suppress a novel negative feedback loo... | BeFree | 25673820 | Detail |
0.006 | Malignant neoplasm of pancreas | ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreat... | BeFree | 25753158 | Detail |
0.006 | Malignant neoplasm of pancreas | Selective inhibition of the p38 alternative activation pathway in infiltrating T... | BeFree | 26479921 | Detail |
<0.001 | juvenile myelomonocytic leukemia | NA | BeFree | Detail | |
0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | Combined CagA expression, p-SHP-2 expression, and p-ERK expression showed an inc... | BeFree | 25871616 | Detail |
0.001 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
0.011 | Malignant neoplasm of prostate | MEK/ERK inhibitors are also in clinical trials and the importance of pRB inactiv... | BeFree | 25070358 | Detail |
0.011 | Malignant neoplasm of prostate | Chloride intracellular channel 1 regulates prostate cancer cell proliferation an... | BeFree | 25279971 | Detail |
0.011 | Malignant neoplasm of prostate | Finally, the results demonstrated that AQP3 upregulated matrix metalloproteinase... | BeFree | 25515250 | Detail |
0.011 | Malignant neoplasm of prostate | BP significantly inhibited phosphorylation of Akt and ERK-1/2, JNK and p38 in PC... | BeFree | 25655200 | Detail |
<0.001 | Hematopoietic Neoplasms | NA | BeFree | Detail | |
<0.001 | cardiac sarcoidosis | NA | BeFree | Detail | |
<0.001 | Lymphatic Abnormalities | NA | BeFree | Detail | |
<0.001 | Chronic Infantile Neurological, Cutaneous, and Articular Syndrome | NA | BeFree | Detail | |
0.001 | lupus erythematosus | NA | BeFree | Detail | |
<0.001 | Skeletal dysplasia | NA | BeFree | Detail | |
0.002 | endometrial carcinoma | Functional bioinformatics analysis identified as downstream targets multiple sig... | BeFree | 25686835 | Detail |
<0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | Recurrent tumor | NA | BeFree | Detail | |
<0.001 | Peritoneal Fibrosis | NA | BeFree | Detail | |
<0.001 | Neurodegenerative Disorders | This research highlights new bioactivities for gracilins, such as BACE1 and ERK ... | BeFree | 25724081 | Detail |
<0.001 | Hepatitis C, Chronic | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of esophagus | NA | BeFree | Detail | |
0.003 | Thyroid carcinoma | These results suggest that the AMPK and p38 MAPK signaling pathways may be usefu... | BeFree | 25045295 | Detail |
<0.001 | Squamous cell carcinoma of skin | CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinom... | BeFree | 25256412 | Detail |
0.001 | Malignant glioma | NA | BeFree | Detail | |
<0.001 | Periodic syndrome | NA | BeFree | Detail | |
0.002 | Osteosarcoma of bone | Taken together, data show CTGF elevating MMPs expression and subsequently promot... | BeFree | 25003330 | Detail |
0.002 | Osteosarcoma of bone | Taken together, our data suggest that miR-143 inhibits EGFR signaling through it... | BeFree | 25227664 | Detail |
<0.001 | Costello syndrome (disorder) | NA | BeFree | Detail | |
<0.001 | Leukemogenesis | NA | BeFree | Detail | |
<0.001 | Tumor Initiation | NA | BeFree | Detail | |
0.011 | prostate carcinoma | MEK/ERK inhibitors are also in clinical trials and the importance of pRB inactiv... | BeFree | 25070358 | Detail |
0.011 | prostate carcinoma | Chloride intracellular channel 1 regulates prostate cancer cell proliferation an... | BeFree | 25279971 | Detail |
0.011 | prostate carcinoma | Finally, the results demonstrated that AQP3 upregulated matrix metalloproteinase... | BeFree | 25515250 | Detail |
0.011 | prostate carcinoma | BP significantly inhibited phosphorylation of Akt and ERK-1/2, JNK and p38 in PC... | BeFree | 25655200 | Detail |
<0.001 | Hashimoto Disease | Furthermore, BAG3 knockdown increased the HT-induced phosphorylation of ERK afte... | BeFree | 25471019 | Detail |
0.002 | Epithelial ovarian cancer | In conclusion, CrkL protein is required for TGF-β signal pathways through AKT an... | BeFree | 25307974 | Detail |
0.002 | Epithelial ovarian cancer | CXCR7 signaling induced epithelial-mesenchymal transition by AKT and ERK pathway... | BeFree | 25359618 | Detail |
<0.001 | Refractory cancer | By far, the most common clinical resistance mechanism involves reactivation of t... | BeFree | 25320010 | Detail |
0.019 | breast carcinoma | By using specific small hairpin RNAs for MAPK11, we demonstrated that p38β-media... | BeFree | 25066918 | Detail |
0.019 | breast carcinoma | As the MAPK pathway is an important target for treating triple-negative breast c... | BeFree | 25073112 | Detail |
0.019 | breast carcinoma | Western blot analysis data indicate that MAPK/ERK and PI3K/Akt signaling in brea... | BeFree | 25127034 | Detail |
0.019 | breast carcinoma | Activating transcription factor-2 (ATF-2) has been implicated as a tumour suppre... | BeFree | 25141981 | Detail |
0.019 | breast carcinoma | Ubc13 was dispensable for transforming growth factor β (TGFβ)-induced SMAD activ... | BeFree | 25189770 | Detail |
0.019 | breast carcinoma | 6,7-di-O-acetylsinococuline (FK-3000) induces G2/M phase arrest in breast carcin... | BeFree | 25384584 | Detail |
0.019 | breast carcinoma | DUSP4 and MAPK8 interacted with calories to alter breast cancer risk; MAPK1 inte... | BeFree | 25629224 | Detail |
0.019 | breast carcinoma | Computational design, chemical synthesis, and biological evaluation of a novel E... | BeFree | 25742792 | Detail |
0.019 | breast carcinoma | These results suggest that GA impairs the p38 MAPK-AP1 signaling axis, leading t... | BeFree | 25828376 | Detail |
0.019 | breast carcinoma | Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced act... | BeFree | 26006730 | Detail |
0.007 | Carcinoma of lung | The expression of tumour suppressor genes was reduced in tumours from current ve... | BeFree | 24727895 | Detail |
0.007 | Carcinoma of lung | The results indicated that Sorcin may be used as a potential therapeutic target ... | BeFree | 25394367 | Detail |
0.007 | Carcinoma of lung | Here, we reported that the AKT inhibitor perifosine and the MEK\ERK inhibitor ME... | BeFree | 25697899 | Detail |
<0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
0.001 | Secondary malignant neoplasm of lymph node | Cytoplasmic/membranous expression of IL-23 (p19 and p40 subunits) and IL-23R, re... | BeFree | 25015728 | Detail |
0.006 | colon carcinoma | Activation of Rac1-ERK pathway and consequent upregulation of MMP-7 production m... | BeFree | 25136657 | Detail |
0.006 | colon carcinoma | Thymoquinone induces caspase-independent, autophagic cell death in CPT-11-resist... | BeFree | 25611974 | Detail |
0.006 | colon carcinoma | Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway gene... | BeFree | 25889965 | Detail |
0.006 | colon carcinoma | Our results show the importance of p38 MAPK in human colon tumor growth using a ... | BeFree | 25890501 | Detail |
0.009 | stomach carcinoma | Resistin-induced stromal cell-derived factor-1 expression through Toll-like rece... | BeFree | 24929539 | Detail |
0.009 | stomach carcinoma | These data suggest that EGF-induced activation of MMP7 and MMP13 in GC is throug... | BeFree | 25085584 | Detail |
0.009 | stomach carcinoma | Deactivation of phosphorylation of ERK protein is one of the mechanisms of soraf... | BeFree | 25136776 | Detail |
0.009 | stomach carcinoma | These data suggest that heparanase facilitates invasion and migration of human g... | BeFree | 25337202 | Detail |
0.009 | stomach carcinoma | Combined treatment with p38 activator partially blocked the antimetastatic effec... | BeFree | 25502212 | Detail |
0.009 | stomach carcinoma | These results indicated that CARLo-5 might serve as a pro-oncogenic lncRNA that ... | BeFree | 25674211 | Detail |
0.009 | stomach carcinoma | WISP-2 suppressed GC cell metastasis through reversing EMT and suppressing the e... | BeFree | 26291058 | Detail |
0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
0.005 | Central neuroblastoma | CFM-4 and -5 induced apoptosis in NB cells in part by activating pro-apoptotic s... | BeFree | 25033461 | Detail |
0.005 | Central neuroblastoma | Moreover, the data show that inhibition of p38 MAPK signalling potentiates the a... | BeFree | 25086905 | Detail |
0.005 | Central neuroblastoma | A cell-based assay was developed using natively expressed ORL-1 receptors on mou... | BeFree | 25677767 | Detail |
0.005 | Central neuroblastoma | Mechanistically treatment of NBs with small molecule inhibitors of EGFR (erlotin... | BeFree | 25756510 | Detail |
0.005 | Central neuroblastoma | Furthermore, the amount of phosphorylation of the kinase ERK and neurite outgrow... | BeFree | 25921289 | Detail |
<0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
<0.001 | malignant peripheral nerve sheath tumor | NA | BeFree | Detail | |
<0.001 | Kabuki make-up syndrome | RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome. | BeFree | 26280580 | Detail |
<0.001 | malignant pleural mesothelioma | DSF-Cu exposure stimulated apoptosis in MPM cells that involved activation of st... | BeFree | 24690739 | Detail |
0.002 | Rhabdoid Tumor of the Kidney | NA | BeFree | Detail | |
<0.001 | Endothelial dysfunction | NA | BeFree | Detail | |
<0.001 | breast adenocarcinoma | Obacunone exhibits anti-proliferative and anti-aromatase activity in vitro by in... | BeFree | 24927687 | Detail |
<0.001 | Advanced cancer | NA | BeFree | Detail | |
0.120 | Cardiomyopathies | NA | BeFree,CTD_human | Detail | |
<0.001 | Erdheim-Chester disease | NA | BeFree | Detail | |
0.129 | ovarian neoplasm | NA | BeFree,CTD_human,LHGDN | Detail | |
<0.001 | Renal ischaemia | NA | BeFree | Detail | |
<0.001 | Ischemic stroke | NA | BeFree | Detail | |
<0.001 | Primary infection NOS | NA | BeFree | Detail | |
<0.001 | Colorectal cancer metastatic | NA | BeFree | Detail | |
0.080 | coronary restenosis | NA | RGD | Detail | |
<0.001 | Tauopathies | NA | BeFree | Detail | |
<0.001 | Arthritis, Collagen-Induced | NA | BeFree | Detail | |
0.008 | Malignant neoplasm of ovary | These regulatory effects of EC on ovarian cancer cell proliferation, migration a... | BeFree,GAD | 24892518 | Detail |
0.008 | Malignant neoplasm of ovary | MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth fa... | BeFree,GAD | 25176450 | Detail |
0.008 | Malignant neoplasm of ovary | In conclusion, bortezomib may induce ERK phosphorylation to suppress cathepsin B... | BeFree,GAD | 25375375 | Detail |
0.008 | Malignant neoplasm of ovary | We conclude that the carboxy-terminal portion of the MUC16/CA125 protein is onco... | BeFree,GAD | 25965947 | Detail |
0.002 | Squamous cell carcinoma of the head and neck | One potential therapeutic target for HNSCC is the RAS/RAF/MEK/ERK cascade, which... | BeFree | 26053277 | Detail |
<0.001 | Anemia, Diamond-Blackfan | NA | BeFree | Detail | |
<0.001 | sarcoma | NA | BeFree | Detail | |
<0.001 | major depressive disorder | Eighty percent of these genes were functionally associated with a key stress res... | BeFree | 25734512 | Detail |
<0.001 | Cardio-facio-cutaneous syndrome | These results suggest that our new Braf knockin mice recapitulate major features... | BeFree | 25035421 | Detail |
<0.001 | Inflammatory disorder | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
<0.001 | Classical Hodgkin's Lymphoma | Moreover, several signal transduction pathways that are critical for the prolife... | BeFree | 25953622 | Detail |
<0.001 | pulmonary sclerosing hemangioma | The significance of p40 expression in sclerosing hemangioma of lung. | BeFree | 25130377 | Detail |
0.001 | pancreatic ductal adenocarcinoma | Prdx1 associates with the formation of membrane protrusions through modulation o... | BeFree | 25426613 | Detail |
<0.001 | renal carcinoma | NA | BeFree | Detail | |
0.024 | Mammary Neoplasms | The data suggest that ERK activation by Nodal signaling regulates c-myc and p27 ... | BeFree,LHGDN | 25073112 | Detail |
0.024 | Mammary Neoplasms | Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasio... | BeFree,LHGDN | 25656647 | Detail |
<0.001 | drug dependence | NA | BeFree | Detail | |
<0.001 | Angiogenic Switch | Given the multiple context-dependent roles for αvβ3 in angiogenesis and tumor pr... | BeFree | 25249331 | Detail |
<0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
<0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
<0.001 | Xenograft Model | Although it had relatively short half-life in serum, it was shown to be highly s... | BeFree | 25438047 | Detail |
0.008 | colorectal cancer | Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in c... | BeFree | 25051350 | Detail |
0.008 | colorectal cancer | Taken together, the present study demonstrated that BK increases IL-6 production... | BeFree | 25109623 | Detail |
0.008 | colorectal cancer | In conclusion, PXN promotes Bcl-2 phosphorylation at Serine 87 via PXN-mediated ... | BeFree | 25826088 | Detail |
0.008 | colorectal cancer | Taken together, our study's findings indicate that the deregulation of β-catenin... | BeFree | 26267535 | Detail |
<0.001 | androgen independent prostate cancer | BP significantly inhibited phosphorylation of Akt and ERK-1/2, JNK and p38 in PC... | BeFree | 25655200 | Detail |
<0.001 | Invasive Skin Melanoma | NA | BeFree | Detail | |
0.120 | CEROID LIPOFUSCINOSIS, NEURONAL, 6 | NA | CTD_human | Detail | |
0.001 | uterine corpus cancer | Functional bioinformatics analysis identified as downstream targets multiple sig... | BeFree | 25686835 | Detail |
<0.001 | coronary artery disease | NA | BeFree | Detail | |
<0.001 | Parvovirus B19 (disease) | NA | BeFree | Detail | |
<0.001 | Philadelphia chromosome-positive acute lymphoblastic leukemia | We have also shown that metformin activates the ERK pathway in Ph+ALL cells, SUP... | BeFree | 26186064 | Detail |
0.003 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,LHGDN | Detail | |
0.010 | liver carcinoma | Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK thro... | BeFree | 25013376 | Detail |
0.010 | liver carcinoma | The CXCR7-ERK-HNF4α cascade represents a new target for the differentiation ther... | BeFree | 25242412 | Detail |
0.010 | liver carcinoma | These results provide the first evidence that up-regulation of the UII/UT system... | BeFree | 25514221 | Detail |
0.010 | liver carcinoma | These results suggest that SIRT6 is required for TGF-β1/H2O2/HOCl to enhance the... | BeFree | 25683165 | Detail |
0.010 | liver carcinoma | Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma developmen... | BeFree | 25823821 | Detail |
<0.001 | Destructive Arthritis | NA | BeFree | Detail | |
<0.001 | Triple-negative breast carcinoma | Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway pot... | BeFree | 25527500 | Detail |
0.120 | chromosome 22q11.2 deletion syndrome, distal | NA | ORPHANET | Detail | |
<0.001 | Autosomal dominant focal segmental glomerulosclerosis | NA | BeFree | Detail | |
<0.001 | Cavernous Hemangioma of Brain | NA | BeFree | Detail | |
<0.001 | Bare lymphocyte syndrome 2 | NA | BeFree | Detail | |
<0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
<0.001 | Central Nervous System Sensitization | NA | BeFree | Detail | |
<0.001 | Pulmonary arterial hypertension | NA | BeFree | Detail | |
<0.001 | Ischemic Cerebrovascular Accident | NA | BeFree | Detail | |
0.005 | myelodysplastic syndrome | NA | LHGDN | Detail | |
<0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
<0.001 | Parkinson Disease, Familial, Type 1 | NA | BeFree | Detail | |
0.120 | Juvenile arthritis | NA | CTD_human | Detail | |
<0.001 | Triple Negative Breast Neoplasms | In aggressive, triple-negative, basal-like breast cancers, most tumors display i... | BeFree | 25073112 | Detail |
<0.001 | Triple Negative Breast Neoplasms | In the present study we discerned the molecular mechanisms of potential interact... | BeFree | 25527500 | Detail |
0.014 | Infection | NA | LHGDN | Detail | |
<0.001 | Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia | NA | BeFree | Detail | |
<0.001 | achondroplasia | NA | BeFree | Detail | |
0.012 | adenocarcinoma | Of the 44 additional adenocarcinomas, 13 (30%) showed p63 expression; p40 was ne... | BeFree,LHGDN | 25189640 | Detail |
0.012 | adenocarcinoma | The small interfering RNA (siRNA) was used to suppress CrkL in serous papillary ... | BeFree,LHGDN | 25307974 | Detail |
<0.001 | adenoma | NA | BeFree | Detail | |
<0.001 | Alcoholic Intoxication, Chronic | NA | BeFree | Detail | |
0.003 | Alzheimer's disease | This research highlights new bioactivities for gracilins, such as BACE1 and ERK ... | BeFree,LHGDN | 25724081 | Detail |
<0.001 | Anaplasia | NA | BeFree | Detail | |
0.005 | Anoxia | NA | LHGDN | Detail | |
<0.001 | anthrax disease | NA | BeFree | Detail | |
0.001 | arteriosclerosis | NA | BeFree | Detail | |
<0.001 | arthritis | NA | BeFree | Detail | |
0.006 | rheumatoid arthritis | (D) PGC-1β mediated NF-κB transcription in RA-FLS, but did not affect ERK and p3... | BeFree | 25367151 | Detail |
0.006 | rheumatoid arthritis | An involvement of SR-B1 mediated p38 MAPK signaling pathway in serum amyloid A-i... | BeFree | 25932604 | Detail |
0.006 | rheumatoid arthritis | Sprouty2 suppresses the inflammatory responses in rheumatoid arthritis fibroblas... | BeFree | 26265114 | Detail |
<0.001 | asbestosis | NA | BeFree | Detail | |
0.002 | asthma | NA | BeFree | Detail | |
0.001 | Astrocytoma | NA | BeFree | Detail | |
<0.001 | Ataxia | NA | BeFree | Detail | |
0.001 | atherosclerosis | NA | BeFree | Detail | |
0.081 | autistic disorder | The 16p11.2 deletion mouse model of autism exhibits altered cortical progenitor ... | BeFree,MGD | 25698753 | Detail |
<0.001 | Autoimmune Diseases | NA | BeFree | Detail | |
<0.001 | Mental disorders | NA | BeFree | Detail | |
<0.001 | bipolar disorder | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
0.003 | Bowen's Disease | NA | LHGDN | Detail | |
<0.001 | Brain Neoplasms | The naturally secreted and O-GlcNAcylated MIF binds to EGFR, thereby inhibiting ... | BeFree | 26280537 | Detail |
0.021 | Malignant neoplasm of breast | By using specific small hairpin RNAs for MAPK11, we demonstrated that p38β-media... | BeFree,GAD | 25066918 | Detail |
0.021 | Malignant neoplasm of breast | Western blot analysis data indicate that MAPK/ERK and PI3K/Akt signaling in brea... | BeFree,GAD | 25127034 | Detail |
0.021 | Malignant neoplasm of breast | Activating transcription factor-2 (ATF-2) has been implicated as a tumour suppre... | BeFree,GAD | 25141981 | Detail |
0.021 | Malignant neoplasm of breast | Ubc13 was dispensable for transforming growth factor β (TGFβ)-induced SMAD activ... | BeFree,GAD | 25189770 | Detail |
0.021 | Malignant neoplasm of breast | 6,7-di-O-acetylsinococuline (FK-3000) induces G2/M phase arrest in breast carcin... | BeFree,GAD | 25384584 | Detail |
0.021 | Malignant neoplasm of breast | DUSP4 and MAPK8 interacted with calories to alter breast cancer risk; MAPK1 inte... | BeFree,GAD | 25629224 | Detail |
0.021 | Malignant neoplasm of breast | Computational design, chemical synthesis, and biological evaluation of a novel E... | BeFree,GAD | 25742792 | Detail |
0.021 | Malignant neoplasm of breast | These results suggest that GA impairs the p38 MAPK-AP1 signaling axis, leading t... | BeFree,GAD | 25828376 | Detail |
0.021 | Malignant neoplasm of breast | Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced act... | BeFree,GAD | 26006730 | Detail |
<0.001 | Burkitt lymphoma | Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to sp... | BeFree | 24787013 | Detail |
0.005 | Malignant tumor of colon | Activation of Rac1-ERK pathway and consequent upregulation of MMP-7 production m... | BeFree | 25136657 | Detail |
0.005 | Malignant tumor of colon | Thymoquinone induces caspase-independent, autophagic cell death in CPT-11-resist... | BeFree | 25611974 | Detail |
0.005 | Malignant tumor of colon | Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway gene... | BeFree | 25889965 | Detail |
0.005 | Malignant tumor of colon | Our results show the importance of p38 MAPK in human colon tumor growth using a ... | BeFree | 25890501 | Detail |
0.001 | Malignant neoplasm of endometrium | Functional bioinformatics analysis identified as downstream targets multiple sig... | BeFree | 25686835 | Detail |
<0.001 | Rectal Carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of thyroid | These results suggest that the AMPK and p38 MAPK signaling pathways may be usefu... | BeFree | 25045295 | Detail |
<0.001 | Bronchioloalveolar Adenocarcinoma | NA | BeFree | Detail | |
<0.001 | mucinous adenocarcinoma | NA | BeFree | Detail | |
0.007 | Non-small cell lung carcinoma | Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contrib... | BeFree | 25284075 | Detail |
0.007 | Non-small cell lung carcinoma | KRAS is frequently mutated in non-small cell lung cancers (NSCLC), resulting in ... | BeFree | 25342139 | Detail |
0.007 | Non-small cell lung carcinoma | Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small... | BeFree | 25400829 | Detail |
0.007 | Non-small cell lung carcinoma | FOXM1 regulated by ERK pathway mediates TGF-β1-induced EMT in NSCLC. | BeFree | 25700356 | Detail |
0.002 | renal cell carcinoma | Downregulation of tNASP inhibits proliferation through regulating cell cycle-rel... | BeFree | 25669170 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
Licochalcone-A induces intrinsic and extrinsic apoptosis via ERK1/2 and p38 phosphorylation-mediated... | DisGeNET | Detail |
Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CXCL12-CXCR7 signaling activates ERK and Akt pathways in human choriocarcinoma cells. | DisGeNET | Detail |
In TNBS-induced mouse colitis models, we observed the up-regulation of VPS4B was accompanied with th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon... | DisGeNET | Detail |
Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in colorectal cancer thr... | DisGeNET | Detail |
Taken together, the present study demonstrated that BK increases IL-6 production via B2R and the ERK... | DisGeNET | Detail |
In conclusion, PXN promotes Bcl-2 phosphorylation at Serine 87 via PXN-mediated ERK activation, and ... | DisGeNET | Detail |
Taken together, our study's findings indicate that the deregulation of β-catenin by ERK2-activated C... | DisGeNET | Detail |
TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycl... | DisGeNET | Detail |
Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization... | DisGeNET | Detail |
Vacuolar protein sorting 4B regulates apoptosis of intestinal epithelial cells via p38 MAPK in Crohn... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results indicated the considerably aberrant MAPK signaling in both insulin-sensitive tissues of ... | DisGeNET | Detail |
Our results indicate that an MKP-3 pathway might regulate ERK dephosphorylation through Nox4 during ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Lipoxin A4 suppresses the development of endometriosis in an ALX receptor-dependent manner via the p... | DisGeNET | Detail |
Up-regulation of Bcl-2 by CD147 Through ERK Activation Results in Abnormal Cell Survival in Human En... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taken together, p38 MAPK-MK2-HuR signalling may enhance the potential of intrinsic (EGFRvIII) and ex... | DisGeNET | Detail |
Application of a specific extracellular-related kinase 1/2 (ERK1/2) inhibitor, but not application o... | DisGeNET | Detail |
Here we propose that the blinding of cell-cell contact sensing in gliomas is caused by an unusual me... | DisGeNET | Detail |
Furthermore, AND did not induce apoptosis or activate ERK and p53 in primary cultured astrocyte cell... | DisGeNET | Detail |
Taken together, our findings showed that HDAC3 contributed to VM in gliomas, possibly through the PI... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Syk and ERK may serve as new therapeutic targets for interfering with ADE-induced cytokine expressio... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The results of BNDF research show that neurotrophins regulate miRNAs in at least three ways: (1) ERK... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The sEng, sFlt-1, and interleukin-6 were up-regulated, whereas the VEGF and PlGF were down-regulated... | DisGeNET | Detail |
These results indicate that high AR expression in the context of hyperglycemia and insulin deficienc... | DisGeNET | Detail |
Our results indicated the considerably aberrant MAPK signaling in both insulin-sensitive tissues of ... | DisGeNET | Detail |
Irisin treatment significantly increased insulin-like growth factor 1 and decreased myostatin gene e... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Roles of p38 MAPK in the regulation of the inflammatory response to swine influenza virus-induced ac... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling... | DisGeNET | Detail |
We also found that blocking ET(A)R via BQ-123 interferes with ERK phosphorylation and CLL pro-surviv... | DisGeNET | Detail |
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
At the molecular level, reduced activation of ERK MAPK, but not Akt, was observed in lung tumours of... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We discovered that YC-1 induces apoptosis and inhibits tumour growth of breast cancer cells via down... | DisGeNET | Detail |
Mechanistically, SHP2/ERK inhibition impedes c-Myc transcriptional activity, which results in the re... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activatio... | DisGeNET | Detail |
Deactivation of phosphorylation of ERK protein is one of the mechanisms of sorafenib inhibiting gast... | DisGeNET | Detail |
These data suggest that heparanase facilitates invasion and migration of human gastric cancer cells ... | DisGeNET | Detail |
Combined treatment with p38 activator partially blocked the antimetastatic effects of baicalein, whi... | DisGeNET | Detail |
These results indicated that CARLo-5 might serve as a pro-oncogenic lncRNA that promotes proliferati... | DisGeNET | Detail |
WISP-2 suppressed GC cell metastasis through reversing EMT and suppressing the expression and activi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mesothelioma tumors are locally invasive and our results clearly suggest that acivins have a tumor-p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In summary, our results suggest that quercetin suppresses the proliferation of MM cells by down-regu... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MAPK1 and RAF1 were responsible for most of this crosstalk (80%), likely reflecting their central ro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mechanistically, knockdown of FAP inactivated PTEN/PI3K/AKT and Ras-ERK and its downstream signaling... | DisGeNET | Detail |
Ubc13 was dispensable for transforming growth factor β (TGFβ)-induced SMAD activation but was requir... | DisGeNET | Detail |
The oncogene ABL1 was a direct miR-3127-5p target, and miR-3127-5p regulated the activation of the A... | DisGeNET | Detail |
In conclusion, these findings demonstrate that EMT can be regulated by the CCL19/CXCR7 axis in epith... | DisGeNET | Detail |
In conclusion, this study suggested that EMT process can be triggered by the BMP2/BMPR axis in gastr... | DisGeNET | Detail |
Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 M... | DisGeNET | Detail |
We also show that mice that have tumors with intrinsically high levels of active AKT and ERK are mor... | DisGeNET | Detail |
WISP-2 suppressed GC cell metastasis through reversing EMT and suppressing the expression and activi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
CFM-4 and -5 induced apoptosis in NB cells in part by activating pro-apoptotic stress-activated kina... | DisGeNET | Detail |
Moreover, the data show that inhibition of p38 MAPK signalling potentiates the anti-neuroblastoma ac... | DisGeNET | Detail |
A cell-based assay was developed using natively expressed ORL-1 receptors on mouse neuroblastoma cel... | DisGeNET | Detail |
Mechanistically treatment of NBs with small molecule inhibitors of EGFR (erlotinib, cetuximab) and E... | DisGeNET | Detail |
Furthermore, the amount of phosphorylation of the kinase ERK and neurite outgrowth increased upon Cb... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Moving beyond BRAFV600 targeting, a number of other molecular subsets--such as mutations in MEK, NRA... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taking together, we demonstrate here for the first time that Arg-II causes eNOS-uncoupling through a... | DisGeNET | Detail |
Current data exclude a major function of these syntrophins in ABCA1 activity and insulin release but... | DisGeNET | Detail |
Our data suggest that H2S prevents the development of opioid withdrawal-induced hyperalgesia via sup... | DisGeNET | Detail |
Our results showed that increased basal COL10A1 expression in OA hMSCs was significantly suppressed ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taken together, data show CTGF elevating MMPs expression and subsequently promoting tumor metastasis... | DisGeNET | Detail |
Taken together, our data suggest that miR-143 inhibits EGFR signaling through its downstream ERK/MAP... | DisGeNET | Detail |
These regulatory effects of EC on ovarian cancer cell proliferation, migration and invasion were ass... | DisGeNET | Detail |
MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the P... | DisGeNET | Detail |
In conclusion, bortezomib may induce ERK phosphorylation to suppress cathepsin B and inhibit the cat... | DisGeNET | Detail |
We conclude that the carboxy-terminal portion of the MUC16/CA125 protein is oncogenic in NIH/3T3 cel... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ERK-mediated phosphorylation of TFAM downregulates mitochondrial transcription: implications for Par... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We tested RDEA119, a specific MEK1/2 (MAPK extracellular signal-regulated kinase [ERK] kinase) inhib... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MEK/ERK inhibitors are also in clinical trials and the importance of pRB inactivation in prostate ca... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taken together, our data suggest that miR99a inhibits MMP7 and MMP13 through PI3k/Akt and ERK/MAPK s... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
When expressed in rat pheochromocytoma cell line cells, the R151C, R160W and D294H MC1R variants ass... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Eighty percent of these genes were functionally associated with a key stress response signalling cas... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Subjects with varicocele demonstrated a significant negative correlation between head morphological ... | DisGeNET | Detail |
Increased activation of mitogen-activated protein kinase p38 and its substrate heat-shock protein 27... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antivi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exo... | DisGeNET | Detail |
Lupalbigenin treatment significantly down-regulated survival proteins, including protein kinase B (p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
LATS2 mRNA level was found to be a significant independent predictor for survival status (disease-fr... | DisGeNET | Detail |
Genetic alterations affecting the MAPK/ERK pathway are common in lung adenocarcinoma (LAD). | DisGeNET | Detail |
To elucidate how EGFR signaling is linked to metabolic activity, we investigated the involvement of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and enhanced anchorage-... | DisGeNET | Detail |
ARB blocked A2-induced GBC cell growth and activated ERK. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, while p53R2, a p53-inducible peptide involved in the synthesis of dNTPs normally works ... | DisGeNET | Detail |
Given the multiple context-dependent roles for αvβ3 in angiogenesis and tumor progression, our novel... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Production of reactive oxygen species (ROS) and activation of p38 MAPK have a central role in trigge... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
WWOX suppresses cell growth and induces cell apoptosis via inhibition of P38 nuclear translocation i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and enhanced anchorage-... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large intestinal carcinoma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ARB blocked A2-induced GBC cell growth and activated ERK. | DisGeNET | Detail |
Further analysis showed that Cyr61 seemed to activate phosphatidylinositol 3-kinase (PI3K) but not e... | DisGeNET | Detail |
ERK pathway knockdown suppressed pancreatic cancer cell proliferation, invasion, and angiogenesis. | DisGeNET | Detail |
This fission is driven by Erk2-mediated phosphorylation of Drp1 on Serine 616, and both this phospho... | DisGeNET | Detail |
We propose that dual PI3K/mTOR inhibitors suppress a novel negative feedback loop mediated by mTORC2... | DisGeNET | Detail |
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer. | DisGeNET | Detail |
Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits panc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Analysis of western blotting data showed that total protein isoforms of Raf, MEK and ERK were simila... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our investigation of the molecular mechanisms underlying these effects revealed that mortalin deplet... | DisGeNET | Detail |
Moreover, our results also showed that downregulation of NOB1 was able to significantly activate con... | DisGeNET | Detail |
In addition, Ad/sh-NOB1 combined with DOX treatment significantly increased activation of the p38 MA... | DisGeNET | Detail |
By using specific small hairpin RNAs for MAPK11, we demonstrated that p38β-mediated p38 activity in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The expression of tumour suppressor genes was reduced in tumours from current versus never-smoking l... | DisGeNET | Detail |
The results indicated that Sorcin may be used as a potential therapeutic target for MDR through inhi... | DisGeNET | Detail |
Here, we reported that the AKT inhibitor perifosine and the MEK\ERK inhibitor MEK-162 synergisticall... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Guanine nucleotide binding protein alpha13 (GNA13) and protein tyrosine phosphatase type IVA (PTP4A)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genome-wide analyses have identified four major signaling nodes that are most frequently altered in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell inv... | DisGeNET | Detail |
In this article, Paul B. Chapman, MD, Memorial Sloan Kettering Cancer Center, summarizes the recent ... | DisGeNET | Detail |
Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells. | DisGeNET | Detail |
Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK pathway... | DisGeNET | Detail |
Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal s... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The data indicate that CIN genomes harbor unfixed mutations in addition to human papilloma virus inf... | DisGeNET | Detail |
In conclusion, bortezomib may induce ERK phosphorylation to suppress cathepsin B and inhibit the cat... | DisGeNET | Detail |
Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliom... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells. | DisGeNET | Detail |
Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
ERK pathway knockdown suppressed pancreatic cancer cell proliferation, invasion, and angiogenesis. | DisGeNET | Detail |
This fission is driven by Erk2-mediated phosphorylation of Drp1 on Serine 616, and both this phospho... | DisGeNET | Detail |
We propose that dual PI3K/mTOR inhibitors suppress a novel negative feedback loop mediated by mTORC2... | DisGeNET | Detail |
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer. | DisGeNET | Detail |
Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits panc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Combined CagA expression, p-SHP-2 expression, and p-ERK expression showed an increased positive pred... | DisGeNET | Detail |
NA | DisGeNET | Detail |
MEK/ERK inhibitors are also in clinical trials and the importance of pRB inactivation in prostate ca... | DisGeNET | Detail |
Chloride intracellular channel 1 regulates prostate cancer cell proliferation and migration through ... | DisGeNET | Detail |
Finally, the results demonstrated that AQP3 upregulated matrix metalloproteinase‑3 (MMP‑3) expressio... | DisGeNET | Detail |
BP significantly inhibited phosphorylation of Akt and ERK-1/2, JNK and p38 in PC-3 (immunoblotting),... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Functional bioinformatics analysis identified as downstream targets multiple signaling pathways pote... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and prov... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results suggest that the AMPK and p38 MAPK signaling pathways may be useful therapeutic target... | DisGeNET | Detail |
CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinoma skin lesions and p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taken together, data show CTGF elevating MMPs expression and subsequently promoting tumor metastasis... | DisGeNET | Detail |
Taken together, our data suggest that miR-143 inhibits EGFR signaling through its downstream ERK/MAP... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MEK/ERK inhibitors are also in clinical trials and the importance of pRB inactivation in prostate ca... | DisGeNET | Detail |
Chloride intracellular channel 1 regulates prostate cancer cell proliferation and migration through ... | DisGeNET | Detail |
Finally, the results demonstrated that AQP3 upregulated matrix metalloproteinase‑3 (MMP‑3) expressio... | DisGeNET | Detail |
BP significantly inhibited phosphorylation of Akt and ERK-1/2, JNK and p38 in PC-3 (immunoblotting),... | DisGeNET | Detail |
Furthermore, BAG3 knockdown increased the HT-induced phosphorylation of ERK after HT treatment, and ... | DisGeNET | Detail |
In conclusion, CrkL protein is required for TGF-β signal pathways through AKT and ERK pathway, which... | DisGeNET | Detail |
CXCR7 signaling induced epithelial-mesenchymal transition by AKT and ERK pathways in epithelial ovar... | DisGeNET | Detail |
By far, the most common clinical resistance mechanism involves reactivation of the MAPK (RAF/MEK/ERK... | DisGeNET | Detail |
By using specific small hairpin RNAs for MAPK11, we demonstrated that p38β-mediated p38 activity in ... | DisGeNET | Detail |
As the MAPK pathway is an important target for treating triple-negative breast cancers, upstream Nod... | DisGeNET | Detail |
Western blot analysis data indicate that MAPK/ERK and PI3K/Akt signaling in breast cancer cells with... | DisGeNET | Detail |
Activating transcription factor-2 (ATF-2) has been implicated as a tumour suppressor in breast cance... | DisGeNET | Detail |
Ubc13 was dispensable for transforming growth factor β (TGFβ)-induced SMAD activation but was requir... | DisGeNET | Detail |
6,7-di-O-acetylsinococuline (FK-3000) induces G2/M phase arrest in breast carcinomas through p38 MAP... | DisGeNET | Detail |
DUSP4 and MAPK8 interacted with calories to alter breast cancer risk; MAPK1 interacted with DOBS, di... | DisGeNET | Detail |
Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI0... | DisGeNET | Detail |
These results suggest that GA impairs the p38 MAPK-AP1 signaling axis, leading to the repression of ... | DisGeNET | Detail |
Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK ... | DisGeNET | Detail |
The expression of tumour suppressor genes was reduced in tumours from current versus never-smoking l... | DisGeNET | Detail |
The results indicated that Sorcin may be used as a potential therapeutic target for MDR through inhi... | DisGeNET | Detail |
Here, we reported that the AKT inhibitor perifosine and the MEK\ERK inhibitor MEK-162 synergisticall... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cytoplasmic/membranous expression of IL-23 (p19 and p40 subunits) and IL-23R, respectively were over... | DisGeNET | Detail |
Activation of Rac1-ERK pathway and consequent upregulation of MMP-7 production may contribute to the... | DisGeNET | Detail |
Thymoquinone induces caspase-independent, autophagic cell death in CPT-11-resistant lovo colon cance... | DisGeNET | Detail |
Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway genes in colon cancer HT... | DisGeNET | Detail |
Our results show the importance of p38 MAPK in human colon tumor growth using a preclinical model, a... | DisGeNET | Detail |
Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activatio... | DisGeNET | Detail |
These data suggest that EGF-induced activation of MMP7 and MMP13 in GC is through phosphatidylinosit... | DisGeNET | Detail |
Deactivation of phosphorylation of ERK protein is one of the mechanisms of sorafenib inhibiting gast... | DisGeNET | Detail |
These data suggest that heparanase facilitates invasion and migration of human gastric cancer cells ... | DisGeNET | Detail |
Combined treatment with p38 activator partially blocked the antimetastatic effects of baicalein, whi... | DisGeNET | Detail |
These results indicated that CARLo-5 might serve as a pro-oncogenic lncRNA that promotes proliferati... | DisGeNET | Detail |
WISP-2 suppressed GC cell metastasis through reversing EMT and suppressing the expression and activi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
CFM-4 and -5 induced apoptosis in NB cells in part by activating pro-apoptotic stress-activated kina... | DisGeNET | Detail |
Moreover, the data show that inhibition of p38 MAPK signalling potentiates the anti-neuroblastoma ac... | DisGeNET | Detail |
A cell-based assay was developed using natively expressed ORL-1 receptors on mouse neuroblastoma cel... | DisGeNET | Detail |
Mechanistically treatment of NBs with small molecule inhibitors of EGFR (erlotinib, cetuximab) and E... | DisGeNET | Detail |
Furthermore, the amount of phosphorylation of the kinase ERK and neurite outgrowth increased upon Cb... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome. | DisGeNET | Detail |
DSF-Cu exposure stimulated apoptosis in MPM cells that involved activation of stress-activated prote... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Obacunone exhibits anti-proliferative and anti-aromatase activity in vitro by inhibiting the p38 MAP... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These regulatory effects of EC on ovarian cancer cell proliferation, migration and invasion were ass... | DisGeNET | Detail |
MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the P... | DisGeNET | Detail |
In conclusion, bortezomib may induce ERK phosphorylation to suppress cathepsin B and inhibit the cat... | DisGeNET | Detail |
We conclude that the carboxy-terminal portion of the MUC16/CA125 protein is oncogenic in NIH/3T3 cel... | DisGeNET | Detail |
One potential therapeutic target for HNSCC is the RAS/RAF/MEK/ERK cascade, which is one of the major... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Eighty percent of these genes were functionally associated with a key stress response signalling cas... | DisGeNET | Detail |
These results suggest that our new Braf knockin mice recapitulate major features of RASopathies and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Moreover, several signal transduction pathways that are critical for the proliferation and survival ... | DisGeNET | Detail |
The significance of p40 expression in sclerosing hemangioma of lung. | DisGeNET | Detail |
Prdx1 associates with the formation of membrane protrusions through modulation of the activity of p3... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The data suggest that ERK activation by Nodal signaling regulates c-myc and p27 proteins post-transl... | DisGeNET | Detail |
Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasion through inhibiting... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Given the multiple context-dependent roles for αvβ3 in angiogenesis and tumor progression, our novel... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Although it had relatively short half-life in serum, it was shown to be highly significant anti-tumo... | DisGeNET | Detail |
Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in colorectal cancer thr... | DisGeNET | Detail |
Taken together, the present study demonstrated that BK increases IL-6 production via B2R and the ERK... | DisGeNET | Detail |
In conclusion, PXN promotes Bcl-2 phosphorylation at Serine 87 via PXN-mediated ERK activation, and ... | DisGeNET | Detail |
Taken together, our study's findings indicate that the deregulation of β-catenin by ERK2-activated C... | DisGeNET | Detail |
BP significantly inhibited phosphorylation of Akt and ERK-1/2, JNK and p38 in PC-3 (immunoblotting),... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Functional bioinformatics analysis identified as downstream targets multiple signaling pathways pote... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We have also shown that metformin activates the ERK pathway in Ph+ALL cells, SUP-B15, a side effect ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK sig... | DisGeNET | Detail |
The CXCR7-ERK-HNF4α cascade represents a new target for the differentiation therapy of HCC. | DisGeNET | Detail |
These results provide the first evidence that up-regulation of the UII/UT system may enhance prolife... | DisGeNET | Detail |
These results suggest that SIRT6 is required for TGF-β1/H2O2/HOCl to enhance the tumorigenicity of H... | DisGeNET | Detail |
Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In aggressive, triple-negative, basal-like breast cancers, most tumors display increased MEK and ERK... | DisGeNET | Detail |
In the present study we discerned the molecular mechanisms of potential interaction between the endo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Of the 44 additional adenocarcinomas, 13 (30%) showed p63 expression; p40 was negative in all cases. | DisGeNET | Detail |
The small interfering RNA (siRNA) was used to suppress CrkL in serous papillary cystic adenocarcinom... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and prov... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
(D) PGC-1β mediated NF-κB transcription in RA-FLS, but did not affect ERK and p38. | DisGeNET | Detail |
An involvement of SR-B1 mediated p38 MAPK signaling pathway in serum amyloid A-induced angiogenesis ... | DisGeNET | Detail |
Sprouty2 suppresses the inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The 16p11.2 deletion mouse model of autism exhibits altered cortical progenitor proliferation and br... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The naturally secreted and O-GlcNAcylated MIF binds to EGFR, thereby inhibiting the binding of EGF t... | DisGeNET | Detail |
By using specific small hairpin RNAs for MAPK11, we demonstrated that p38β-mediated p38 activity in ... | DisGeNET | Detail |
Western blot analysis data indicate that MAPK/ERK and PI3K/Akt signaling in breast cancer cells with... | DisGeNET | Detail |
Activating transcription factor-2 (ATF-2) has been implicated as a tumour suppressor in breast cance... | DisGeNET | Detail |
Ubc13 was dispensable for transforming growth factor β (TGFβ)-induced SMAD activation but was requir... | DisGeNET | Detail |
6,7-di-O-acetylsinococuline (FK-3000) induces G2/M phase arrest in breast carcinomas through p38 MAP... | DisGeNET | Detail |
DUSP4 and MAPK8 interacted with calories to alter breast cancer risk; MAPK1 interacted with DOBS, di... | DisGeNET | Detail |
Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI0... | DisGeNET | Detail |
These results suggest that GA impairs the p38 MAPK-AP1 signaling axis, leading to the repression of ... | DisGeNET | Detail |
Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK ... | DisGeNET | Detail |
Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exo... | DisGeNET | Detail |
Activation of Rac1-ERK pathway and consequent upregulation of MMP-7 production may contribute to the... | DisGeNET | Detail |
Thymoquinone induces caspase-independent, autophagic cell death in CPT-11-resistant lovo colon cance... | DisGeNET | Detail |
Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway genes in colon cancer HT... | DisGeNET | Detail |
Our results show the importance of p38 MAPK in human colon tumor growth using a preclinical model, a... | DisGeNET | Detail |
Functional bioinformatics analysis identified as downstream targets multiple signaling pathways pote... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results suggest that the AMPK and p38 MAPK signaling pathways may be useful therapeutic target... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib se... | DisGeNET | Detail |
KRAS is frequently mutated in non-small cell lung cancers (NSCLC), resulting in activation of the ME... | DisGeNET | Detail |
Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer ce... | DisGeNET | Detail |
FOXM1 regulated by ERK pathway mediates TGF-β1-induced EMT in NSCLC. | DisGeNET | Detail |
Downregulation of tNASP inhibits proliferation through regulating cell cycle-related proteins and in... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386505388 dbSNP
- Genome
- hg19
- Position
- chr22:22,113,946-22,221,970
- Variant Type
- snv
Genome browser